Study Title
Detection and Monitoring of Metastasis by 18F-DCFPyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer and Negative Conventional Imaging
Study Details
Description:
This study aimed to evaluate the diagnostic performance of 18F-DCFPyL (PyL) PET/CT in subjects presenting not previously treated for castration resistant prostate cancer and showing negative or equivocal findings per institutional standard of care conventional imaging
Sponsor:
CHU de Quebec-Universite Laval
Contacts:
Marjorie Besançon, PhDmarjorie.besancon@crchudequebec.ulaval.ca
418 525-4444 ext 20417
Marilyn Savardmarilyn.savard@crchudequebec.ulaval.ca
418 525-4444 ext 16848
Government Study Link:
NCT04655365 - Click here to see study onClinicalTrials.gov
© 2021 XCancer Software LLC
Contact XCancer: 402-991-8468